WO2020159783A1 - Prosthetic valve - Google Patents

Prosthetic valve Download PDF

Info

Publication number
WO2020159783A1
WO2020159783A1 PCT/US2020/014701 US2020014701W WO2020159783A1 WO 2020159783 A1 WO2020159783 A1 WO 2020159783A1 US 2020014701 W US2020014701 W US 2020014701W WO 2020159783 A1 WO2020159783 A1 WO 2020159783A1
Authority
WO
WIPO (PCT)
Prior art keywords
frame
skirt
prosthetic valve
fold
radially
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2020/014701
Other languages
English (en)
French (fr)
Inventor
Liron TAYEB
Tamir S. Levi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences Corp
Original Assignee
Edwards Lifesciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP25161107.5A priority Critical patent/EP4541318A3/en
Priority to JP2021543425A priority patent/JP7662526B2/ja
Priority to CN202080020800.3A priority patent/CN113613594B/zh
Priority to EP20706922.0A priority patent/EP3917453B1/en
Priority to CN202411580053.5A priority patent/CN119857008A/zh
Application filed by Edwards Lifesciences Corp filed Critical Edwards Lifesciences Corp
Publication of WO2020159783A1 publication Critical patent/WO2020159783A1/en
Priority to US17/359,964 priority patent/US12201519B2/en
Anticipated expiration legal-status Critical
Priority to US18/969,583 priority patent/US20250090318A1/en
Priority to US19/029,188 priority patent/US20250169947A1/en
Priority to JP2025061263A priority patent/JP2025096362A/ja
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2415Manufacturing methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/243Deployment by mechanical expansion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0057Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof stretchable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0066Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof shrinkable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0091Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements connected by a hinged linkage mechanism, e.g. of the single-bar or multi-bar linkage type

Definitions

  • the present disclosure concerns embodiments of a prosthetic valve for implantation into body ducts, such as native heart valve annuluses, and methods of implanting the prosthetic valve.
  • the human heart can suffer from various valvular diseases. These valvular diseases can result in significant malfunctioning of the heart and ultimately require replacement of the native valve with an artificial valve.
  • valvular diseases can result in significant malfunctioning of the heart and ultimately require replacement of the native valve with an artificial valve.
  • a prosthetic heart valve is configured to be implanted in a much less invasive procedure by way of catheterization.
  • a prosthetic heart valve can be mounted in a crimped state on the distal end of a delivery device and advanced through the patient’s vasculature (e.g., through a femoral artery and the aorta) until the prosthetic valve reaches the implantation site in the heart.
  • the prosthetic valve is then expanded to its functional size, for example, by inflating a balloon on which the prosthetic valve is mounted, or by deploying the prosthetic valve from a sheath of the delivery device so that the prosthetic valve can self-expand to its functional size, or by other means.
  • Known prosthetic valves can be radially compressible and expandable between a radially compressed state and a radially expanded state.
  • the prosthetic valves can be crimped on an implant delivery apparatus in the radially compressed state during delivery, and then expanded to the radially expanded state once the prosthetic valve reaches the implantation site.
  • a prosthetic valve typically includes a frame with a valvular structure (e.g., leaflets) mounted therein, an inner skirt secured to the inside of the frame, and optionally, an outer skirt secured to the exterior of the frame.
  • the inner skirt can serve several functions.
  • the inner skirt can function as a sealing member to prevent (or decrease) paravalvular leakage and to anchor the leaflets to the frame.
  • the outer skirt can cooperate with the inner skirt to further reduce or avoid paravalvular leakage after implantation of the valve.
  • the inner and outer skirts can be secured to the frame by suturing or stitching the fabric of the respective skirts to the frame.
  • the inner skirt desirably comprises a tough, tear resistant material such as
  • skirts formed from conventional woven PET or similar fabrics are substantially non elastic, and thus can hardly be stretched.
  • the lack of skirt elasticity can create a challenge for crimping the prosthetic valve.
  • crimping the prosthetic valve tends to reduce the frame’s diameter while elongate the frame in the axial direction.
  • the skirt is usually sutured to the frame, the inelasticity of the skirt can constrain the axial elongation of the frame.
  • crimping can create substantial stress of the fabric at the suture points such that it may lead to suture tears, fabric tear, or frame distortion.
  • constraint of the skirt during crimping can be localized such that some areas of the skirt may conform to the frame more tightly than other areas. Such non-uniform tightening can lead to undesired uneven attachment of the skirt to the frame, and can further cause tearing of sutures and/or the fabric, or distortion of the frame.
  • One possible solution to this problem is to size the skirt such that there is slack in the radial direction when the prosthetic valve is in the radially expanded state. The slack permits axial elongation of the prosthetic valve during the crimping process without being restricted or constrained by the skirt.
  • Prosthetic valves disclosed herein can be implanted within any of the native valves of the heart (the aortic, mitral, tricuspid and pulmonary valves).
  • the prosthetic valve can be delivered through the vasculature and implanted to the heart of a patient by using a delivery apparatus.
  • Certain embodiments of the disclosure concern a prosthetic valve having an annular frame, a valvular structure, and an annular skirt.
  • the annular frame can be radially expandable and compressible between a radially compressed configuration and a radially expanded configuration.
  • the valvular structure can be positioned within the frame and configured to permit the flow of blood through the prosthetic valve in one direction and block the flow of blood in an opposing direction.
  • the annular skirt can have an outer portion covering at least a portion of an outer surface of the frame and an inner portion covering at least a portion of an inner surface of the frame. The skirt can be folded around an inflow end of the frame so as to define a fold between the inner portion and outer portion.
  • the skirt can be sized such that when the frame is in the expanded configuration, the outer portion of the skirt conforms to the outer surface of the frame and the inflow end of the frame is axially spaced from the fold to form an axially extending gap between the frame and the fold, and when the frame is radially compressed from the expanded configuration to the compressed configuration, the inflow end of the frame moves axially within the gap closer to the fold.
  • the outer portion of the skirt can be secured to a row of stmts defining an outflow end of the frame.
  • the outer portion of the skirt can be stretched in a
  • the skirt can comprise a non-elastic fabric.
  • the fabric can be woven using polyethylene terephthalate fibers in both warp and weft directions.
  • the skirt can be woven from a first set of fibers oriented in a first direction and a second set of fibers oriented in a second direction, neither the first nor the second direction being perpendicular to the fold.
  • the first direction can be generally perpendicular to the second direction.
  • the second direction can form an angle about 45 degrees relative to the fold.
  • the valvular structure can include a plurality of leaflets, each leaflet having an inflow edge portion.
  • the inflow edge portions of the leaflets can define an undulating shape.
  • the inner portion of the skirt can have an undulating outflow edge sutured to the inflow edge portions of the leaflets.
  • the prosthetic valve can include a tether coupled to the skirt.
  • the tether can be configured to prevent the fold from moving inside the frame when the frame is radially expanded from the compressed configuration to the expanded configuration.
  • Certain embodiments of the disclosure also concern a prosthetic valve having an annular frame, a valvular structure, and an annular skirt.
  • the annular frame can have an inflow end and an outflow end, and the frame can be radially expandable and compressible between a radially compressed configuration and a radially expanded configuration.
  • the valvular structure can be positioned within the frame and configured to permit the flow of blood through the prosthetic valve in one direction and block the flow of blood in an opposing direction.
  • the annular skirt can have a fold extending around the inflow end of the frame so as to cover at least a portion of an outer surface of the frame and at least a portion of an inner surface of the frame.
  • an outer portion of the skirt can tightly conform to the outer surface of the frame and the inflow end of the frame can be axially spaced from the fold to form an axially extending gap between the frame and the fold.
  • the inflow end of the frame can extend axially so as to at least partially fill the axially extending gap.
  • the valvular structure can include a plurality of leaflets, each leaflet having an inflow edge portion, and the inflow edge portions of the leaflets can define an undulating, curved scalloped shape that follows a plurality of interconnected stmt segments of the frame along circumferential direction when the frame is in the radially expanded configuration.
  • the outer portion of the skirt can be axially longer than the inner portion of the skirt.
  • the outer portion of the skirt can be stretched in a
  • the prosthetic valve can include a tether coupled to the skirt and extending at an oblique angle relative to a longitudinal axis of the frame such that the tether can apply a tension to the skirt so as to prevent the fold from moving inside the frame when the frame is radially expanded from the compressed configuration to the expanded configuration.
  • the method can include delivering the prosthetic valve in a radially compressed configuration to a target location, the prosthetic valve including an annular frame and an annular skirt having a fold around an inflow end of the frame so as to cover at least a portion of an outer surface of the frame and at least a portion of an inner surface of the frame.
  • the method further includes expanding the prosthetic valve to a radially expanded configuration such that an outer portion of the skirt tightly conforms to the outer surface of the frame, and the inflow end of the frame moves axially away from the fold, thereby forming an axially extending gap between the frame and the fold.
  • the prosthetic valve can further include a valvular structure.
  • the valvular structure can include a plurality of leaflets, each leaflet having an inflow edge portion, and the inflow edge portions of the leaflets can define an undulating, curved scalloped shape that follows a plurality of interconnected stmt segments of the frame along circumferential direction when the frame is in the radially expanded configuration.
  • the outer portion of the skirt can be stretched in a circumferential direction when the frame is in the expanded configuration.
  • the inflow end of the frame when the frame is in the radially compressed configuration, can extend axially all the way to the fold so as to completely fill the axially extending gap.
  • the prosthetic valve can include a tether coupled to the skirt.
  • the tether can be configured to prevent the fold from moving inside the frame when the frame is radially expanded from the compressed configuration to the expanded configuration.
  • a prosthetic valve including an annular frame and an annular skirt covering at least a portion of an outer surface of the frame.
  • the annular frame can have an inflow end and an outflow end, and the frame can be radially expandable and compressible between a radially compressed configuration and a radially expanded configuration.
  • the lower edge of the skirt can extend over the inflow end of the frame.
  • the skirt can be attached to the frame by a plurality of sutures.
  • the sutures can be positioned on a plurality of selected struts of the frame such that the sutures form undulating, scallop- shaped suture lines.
  • Each of the suture lines can form an about 45-degree angle relative to a longitudinal axis of the frame when the frame is in the radially expanded configuration.
  • the skirt can be woven from a first set of non-elastic fibers oriented in a first direction and a second set of non-elastic fibers oriented in a second direction.
  • the first direction can be generally perpendicular to the second direction which can form an angle about 45 degrees relative to the lower edge of the skirt.
  • the skirt can be sized such it tightly conforms to the outer surface of the frame without any slack when the frame is in the radially expanded configuration.
  • the skirt can fold around the inflow end of the frame so that the lower edge of the skirt defines a fold.
  • the inflow end of the frame can be axially spaced from the fold to form an axially extending gap between the frame and the fold.
  • the inflow end of the frame can move axially within the gap closer to the fold.
  • the skirt when the frame is radially compressed, the skirt can billow out to form folded flaps between the scallop-shaped suture lines.
  • each flap can be folded over its adjacent flap in a
  • a prosthetic valve that includes an annular frame having an inflow end and an outflow end, at least one actuator mounted to the frame, and an annular skirt having a fold extending around the inflow end of the frame so as to cover at least a portion of an outer surface of the frame and at least a portion of an inner surface of the frame.
  • the actuator can be configured to radially expand or compress the frame between a radially compressed configuration and a radially expanded configuration.
  • an outer portion of the skirt can tightly conform to the outer surface of the frame and the inflow end of the frame can be axially spaced from the fold to form an axially extending gap between the frame and the fold.
  • the inflow end of the frame can extend axially so as to at least partially fill the axially extending gap.
  • the at least one actuator can be one of a plurality of actuators mounted to and equally spaced around the inner surface of the frame.
  • the at least one actuator can include a first anchor attached to a first location of the frame, a second anchor secured to a second location of the frame, and a rod extending through the first anchor and the second anchor.
  • the second location can be closer to the inflow end of the frame than the first location.
  • the rod can be configured to increase or decrease a distance between the first and second locations so as to radially compress or radially expand the frame, respectively.
  • the rod can include external threads that are configured to matingly engage with internal threads of the second anchor.
  • the first location can be a junction between two overlaying struts of the frame, and the first anchor can be hingely connected to the junction by a fastener.
  • the at least one actuator can include a rod received at least partially within a sleeve, and the axial movement of the rod relative to the sleeve can cause radial expansion or compression of the frame.
  • the at least one actuator can include a locking mechanism configured to lock the frame in the radially expanded configuration.
  • the at least one actuator can include an attachment member that is configured to form a releasable connection with a corresponding actuation member of a delivery apparatus such that the actuation member of the delivery apparatus can apply force to the at least one actuator for radially compressing or expanding the frame.
  • the prosthetic valve can further include a valvular structure positioned within the frame and configured to permit the flow of blood through the prosthetic valve in one direction and block the flow of blood in an opposing direction.
  • the valvular structure can include a plurality of leaflets, each leaflet having an inflow edge portion, and the inflow edge portions of the leaflets can define an undulating, curved scalloped shape that follows a plurality of interconnected stmt segments of the frame along circumferential direction when the frame is in the radially expanded configuration.
  • the outer portion of the skirt can be axially longer than the inner portion of the skirt.
  • the outer portion of the skirt can have about the same axial length as the inner portion of the skirt.
  • the outer portion of the skirt can be axially shorter than the inner portion of the skirt.
  • the outer portion of the skirt can be stretched in a
  • an upper edge of the outer portion of the skirt can be generally straight before being attached to the frame. [047] In some embodiments, the upper edge of the outer portion of the skirt can be attached to the frame at a plurality of pivot joints formed by overlapping struts of the frame.
  • an upper edge of the outer portion of the skirt can have an undulating shape and is sutured along a row of strut segments of the frame.
  • the prosthetic valve can further include a tether coupled to the skirt and extending at an oblique angle relative to the fold such that the tether applies a tension to the skirt so as to prevent the fold from moving inside the frame when the frame is radially expanded from the compressed configuration to the expanded configuration.
  • the oblique angle can range from about 10° to about 80°. In some embodiments, the oblique angle can range from about 30° to about 60°. In some embodiments, the oblique angle can be about 45°.
  • a first end of the tether can be located at an outflow edge portion of the outer portion of the skirt, and a second end of the tether can be located adjacent the fold.
  • the tether can include a suture that is stitched to the outer portion of the skirt using in-and-out stitches.
  • the tether can include an elastic material.
  • the tether can be one of a plurality of tethers, each of which can form an oblique angle relative to the fold.
  • Certain embodiments of the disclosure also concern a prosthetic valve that includes an annular frame being radially expandable and compressible between a radially compressed configuration and a radially expanded configuration, an annular skirt having an outer portion covering at least a portion of an outer surface of the frame and an inner portion covering at least a portion of an inner surface of the frame, and a tether coupled to the skirt to prevent the fold from moving inside the frame when the frame is radially expanded from the compressed configuration to the expanded configuration.
  • the skirt can be folded around an inflow end of the frame so as to define a fold between the inner portion and outer portion.
  • the skirt can be sized such that when the frame is in the expanded configuration, the outer portion of the skirt can conform to the outer surface of the frame and the inflow end of the frame can be axially spaced from the fold to form an axially extending gap between the frame and the fold, and when the frame is radially compressed from the expanded configuration to the compressed configuration, the inflow end of the frame can move axially within the gap closer to the fold.
  • the prosthetic valve can further include a valvular structure positioned within the frame and configured to permit the flow of blood through the prosthetic valve in one direction and block the flow of blood in an opposing direction.
  • the valvular structure can include a plurality of leaflets, each leaflet having an inflow edge portion, and the inflow edge portions of the leaflets can define an undulating shape.
  • the inner portion of the skirt can have an undulating outflow edge sutured to the inflow edge portions of the leaflets.
  • the outer portion of the skirt can be secured to a row of stmts defining an outflow end of the frame.
  • the outer portion of the skirt can be stretched in a
  • the skirt can include a non-elastic fabric.
  • the fabric can include polyethylene terephthalate fibers.
  • the polyethylene terephthalate fibers can have a thickness of about 20-denier.
  • the polyethylene terephthalate fibers can have an inter-fiber spacing ranging from about 155 fibers per inch to about 180 fibers per inch. In some embodiments, the polyethylene terephthalate fibers can have an inter- fiber spacing about 160 fibers per inch.
  • the skirt can be woven from a first set of fibers oriented in a first direction and a second set of fibers oriented in a second direction, neither the first nor the second direction being perpendicular to the fold.
  • the first direction can be generally perpendicular to the second direction which forms an angle about 45 degrees relative to the fold.
  • the first set of fibers can extend generally parallel to a first set of struts of the frame and the second set of fibers can extend generally parallel to a second set of struts of the frame when the frame is in the expanded configuration, and the second set of struts can overlap the first set of struts to form junctions of the frame.
  • the tether can extend at an oblique angle relative to the fold and the tether can be configured to apply a tension to the skirt when the frame is in the expanded configuration.
  • the oblique angle can be about 45°.
  • a first end of the tether can be located at an outflow edge portion of the outer portion of the skirt, and a second end of the tether can be located adjacent the fold.
  • the tether can include a suture that is stitched to the outer portion of the skirt using in-and-out stitches.
  • the tether can include an elastic material.
  • Certain embodiments of the disclosure also concern a prosthetic valve that includes an annular frame being radially expandable and compressible between a radially compressed configuration and a radially expanded configuration, and an annular outer skirt covering at least a portion of an outer surface of the frame. When the frame is in the radially compressed configuration, portions of the outer skirt can billow out to form longitudinally extending folded flaps.
  • each flap can be further folded in a circumferential direction so as to maintain a low crimping profile of the prosthetic valve.
  • each flap can at least partially overlap an adjacent flap in the circumferential direction.
  • the outer skirt can be connected to stmts of the frame along a zig-zag shaped attachment line. [077] In some embodiments, the outer skirt can be connected to the struts of the frame with sutures along the zig-zag shaped attachment line.
  • the outer skirt can be not connected to any stmts of the frame or other components of the prosthetic valve at locations not along the zig-zag shaped attachment line.
  • the outer skirt can be connected to the frame only along the zig-zag shaped attachment line.
  • the prosthetic valve can further include a plurality of leaflets, each leaflet having an inflow edge portion attached to the struts of the frame along the zig zag shaped attachment line.
  • the flaps can be V-shaped.
  • the prosthetic valve can further include an annular inner skirt covering at least a portion of an inner surface of the frame, and the outer skirt can be connected to the inner skirt via a fold extending around an inflow end of the frame.
  • the outer skirt when the frame is in the radially expanded configuration, can be configured to tightly conform to the outer surface of the frame and the inflow end of the frame can be axially spaced from the fold to form an axially extending gap between the frame and the fold, and when the frame is in the radially compressed
  • the inflow end of the frame can be configured to extend axially so as to at least partially fill the axially extending gap.
  • an axial length of the gap can range from about 4 mm to about 8 mm when the frame is in the radially expanded configuration. In some embodiments, the axial length of the gap can be about 6 mm when the frame is in the radially expanded configuration.
  • the inflow end of the frame can extend axially to and completely fill the gap when the frame is in the radially compressed configuration.
  • the inner skirt can fold inwardly toward an interior of the frame when the frame is in the radially compressed configuration.
  • the prosthetic valve can further include a tether coupled to the outer skirt and extending at an oblique angle relative to the fold such that the tether applies a tension to the outer skirt so as to prevent the fold from moving inside the frame when the frame is radially expanded from the compressed configuration to the expanded configuration.
  • the tether can include a suture that is stitched to the outer skirt using in-and-out stitches.
  • the tether can include an elastic material.
  • Certain embodiments of the disclosure further concern a method of assembling a prosthetic valve.
  • the method can include receiving an annular frame that is radially expandable and compressible between a radially compressed configuration and a radially expanded configuration, and attaching an annular skirt to the frame such that the skirt has an outer portion covering at least a portion of an outer surface of the frame and an inner portion covering at least a portion of an inner surface of the frame.
  • the skirt can be folded around an inflow end of the frame so as to define a fold between the inner portion and outer portion.
  • the skirt can be sized such that when the frame is in the expanded configuration, the outer portion of the skirt can conform to the outer surface of the frame and the inflow end of the frame can be axially spaced from the fold to form an axially extending gap between the frame and the fold, and when the frame is radially compressed from the expanded configuration to the compressed configuration, the inflow end of the frame can move axially within the gap closer to the fold.
  • attaching the annular skirt to the frame can include suturing an upper edge of the inner portion of the skirt to a selected row of stmt segments of the frame from inside the frame.
  • attaching the annular skirt to the frame can include suturing the outer portion of the skirt to a row of struts defining an outflow end of the frame.
  • the method can further include attaching a valvular structure to the frame.
  • the valvular structure can be configured to permit the flow of blood through the prosthetic valve in one direction and block the flow of blood in an opposing direction.
  • the valvular structure can include a plurality of leaflets, each leaflet having an inflow edge portion. The inflow edge portions of the leaflets can define an undulating shape. Attaching the valvular structure to the frame can include suturing the inflow edge portions of the leaflets from inside the frame to a row of interconnected strut segments of the frame along circumferential direction.
  • the method can further include coupling a tether to the skirt in an oblique angle relative to the fold so as to prevent the fold from moving inside the frame when the frame is radially expanded from the compressed configuration to the expanded configuration.
  • Certain embodiments of the disclosure further concern a method including receiving a prosthetic valve comprising an annular frame that is radially expandable and compressible between a radially compressed configuration and a radially expanded configuration and an annular skirt that covers at least a portion of an outer surface of the frame, compressing the frame to the radially compressed configuration so that portions of the skirt billow out to form longitudinally extending folded flaps, and folding the flaps in a circumferential direction.
  • the skirt can be sutured to struts of the frame along a zig-zag shaped attachment line.
  • the prosthetic valve can include a plurality of leaflets, and each leaflet can have an inflow edge portion being attached to the struts of the frame along the zig zag shaped attachment line.
  • the skirt can cover at least a portion of an inner surface of the frame and form a fold around an inflow end of the frame.
  • the skirt can be sized such that when the frame is in the expanded configuration, the inflow end of the frame can be axially spaced from the fold to form an axially extending gap between the frame and the fold, and when the frame is radially compressed from the expanded configuration to the compressed configuration, the inflow end of the frame can move axially within the gap closer to the fold.
  • the prosthetic valve can further include a tether coupled to the skirt at an oblique angle relative to the fold so as to prevent the fold from moving inside the frame when the frame is radially expanded from the compressed configuration to the expanded configuration.
  • the method can further include loading the prosthetic valve into a sheath of a delivery apparatus, inserting the prosthetic valve into a patient, advancing the prosthetic valve through the patient’s vasculature to an implantation site, and radially expanding the prosthetic valve at the implantation site.
  • radially expanding the prosthetic valve can cause the flaps to unfold.
  • the skirt when the frame is in the radially expanded configuration, the skirt can tightly conform to the outer surface of the frame.
  • FIG. 1 shows a perspective view of a prosthetic valve, according to one embodiment.
  • FIG. 2A shows the frame of the prosthetic valve of FIG. 1 shown in a radially compressed configuration.
  • FIG. 2B shows the frame of the prosthetic valve of FIG. 1 shown in a partially radially expanded configuration.
  • FIG. 2C shows the frame of the prosthetic valve of FIG. 1 shown in a fully radially expanded configuration.
  • FIG. 3 shows a side elevational view of the prosthetic valve depicted in FIG. 1 in a radially compressed configuration, the valve further comprising a skirt attached to the frame.
  • FIG. 4 shows a side elevational view of the prosthetic valve depicted in FIG. 3 in a radially expanded configuration.
  • FIG. 5 shows a side cross sectional view of the prosthetic valve when it is fully expanded.
  • FIG. 6 shows a side cross sectional view of the prosthetic valve when it is partially compressed.
  • FIG. 7 shows a side cross section of an outermost portion of the prosthetic valve when it is fully compressed.
  • FIG. 8 shows a flattened view of the skirt.
  • FIG. 9 shows a prospective view of a prosthetic valve, according to an alternative embodiment.
  • FIG. 10 shows a prospective view of a radially expanded frame of a prosthetic valve, according to another embodiment.
  • FIG. 11 shows the frame of FIG. 10 being partially compressed and the outer portion of the skirt folds outwardly.
  • FIG. 12A shows the prosthetic valve of FIG. 9 being fully compressed and the outer portion of the skirt billows out to form folded flaps.
  • FIG. 12B shows the fully compressed prosthetic valve of FIG. 12A wherein the flaps are circumferentially folded.
  • FIG. 12C shows a cross-sectional view of the fully compressed prosthetic valve depicted in FIG. 12B.
  • FIG. 1 shows an exemplary prosthetic valve 10, according to one embodiment.
  • the prosthetic valve 10 can be implanted within the native aortic annulus, although it also can be implanted at other locations in the heart, including within the native mitral valve, the native pulmonary valve, and the native tricuspid valve.
  • the prosthetic valve 10 can include an annular stent or frame 12 having an inflow end 14 and an outflow end 16.
  • the prosthetic valve 10 can also include a valvular structure 18 which is coupled to and supported inside of the frame 12. The valvular structure 18 is configured to regulate the flow of blood through the prosthetic valve 10 from the inflow end 14 to the outflow end 16.
  • the prosthetic valve 10 can further include one or more actuators 50 mounted to and equally spaced around the inner surface of the frame 12.
  • Each of the actuators 50 can be configured to form a releasable connection with one or more respective actuators of a delivery apparatus, as further described below.
  • the valvular structure 18 can include, for example, a leaflet assembly comprising one or more leaflets 20 made of a flexible material.
  • the leaflets 20 can be made from in whole or part, biological material, bio-compatible synthetic materials, or other such materials. Suitable biological material can include, for example, bovine pericardium (or pericardium from other sources).
  • the leaflets 20 can be secured to one another at their adjacent sides to form commissures 22, each of which can be secured to a respective actuator 50 or the frame 12.
  • the valvular structure 18 comprises three leaflets 20, which can be arranged to collapse in a tricuspid arrangement.
  • Each leaflet 20 can have an inflow edge portion 2E
  • the inflow edge portions 21 of the leaflets 20 can define an undulating, curved scalloped shape that follows or tracks a plurality of interconnected stmt segments of the frame 12 in a circumferential direction when the frame 12 is in the radially expanded configuration.
  • the inflow edges of the leaflets can be referred to as a“scallop line.”
  • the inflow edge portions 21 of the leaflets 20 can be sutured to the struts generally along the scallop line.
  • each leaflet 20 By forming the leaflets 20 with this scalloped geometry, stresses on the leaflets 20 are reduced, which in turn improves durability of the valve 10. Moreover, by virtue of the scalloped shape, folds and ripples at the belly of each leaflet 20 (the central region of each leaflet), which can cause early calcification in those areas, can be eliminated or at least minimized.
  • the scalloped geometry also reduces the amount of tissue material used to form valvular structure 18, thereby allowing a smaller, more even crimped profile at the inflow end 14 of the valve 10.
  • transcatheter prosthetic heart valves including the manner in which the valvular structure can be coupled to the frame 12 of the prosthetic valve 10, can be found, for example, in U.S. Patent Nos. 6,730,118, 7,393,360, 7,510,575, 7,993,394 and 8,652,202, and U.S. Patent Application No. 15/978,459, all of which are incorporated herein by reference in their entireties.
  • the prosthetic valve 10 can be radially compressible and expandable between a radially compressed configuration and a radially expanded configuration. FIGS.
  • FIG. 2A-2C show the bare frame 12 of the prosthetic valve 10 (without the leaflets and other components) for purposes of illustrating expansion of the prosthetic valve 10 from the radially compressed configuration to the radially expanded configuration.
  • FIG. 2A shows the frame 12 in the radially compressed configuration
  • FIG. 2B shows the frame 12 in a partially expanded configuration
  • FIG. 2C shows the frame 12 in the fully radially expanded configuration.
  • the prosthetic valve 10 can be mechanically expanded from the radially configuration to the radially expanded configuration.
  • the prosthetic valve 10 can be radially expanded by maintaining the inflow end 14 of the frame 12 at a fixed position while applying a force (F) in the axial direction against the outflow end 16 toward the inflow end 14.
  • the prosthetic valve 10 can be expanded by applying an axial force against the inflow end 14 while maintaining the outflow end 16 at a fixed position, or by applying opposing axial forces to the inflow and outflow ends 14, 16, respectively.
  • each of the actuators 50 can comprise a screw or threaded rod 52, a first anchor in the form of a cylinder or sleeve 54, and a second anchor in the form of a threaded nut 56.
  • the rod 52 extends through the sleeve 54 and the nut 56.
  • the sleeve 54 can be secured to the frame 12, such as with a fastener that forms a hinge at the junction between two struts.
  • Each actuator 50 is configured to increase the distance between the attachment locations of a respective sleeve 54 and nut 56, which causes the frame 12 to elongate axially and compress radially, and to decrease the distance between the attachment locations of a respective sleeve 54 and nut 56, which causes the frame 12 to foreshorten axially and expand radially.
  • each rod 52 can have external threads that engage internal threads of the nut 56 such that rotation of the rod causes corresponding axial movement of the nut 56 toward or away from the sleeve 54 (depending on the direction of rotation of the rod 52).
  • the actuators 50 can be reciprocating type actuators configured to apply axial directed forces to the frame to produce radial expansion and compression of the frame.
  • the rod 52 of each actuator can be fixed axially relative to the sleeve 56 and slidable relative to the sleeve 54.
  • moving the rod 52 distally relative to the sleeve 54 and/or moving the sleeve 54 proximally relative to the rod 52 radially compresses the frame.
  • moving the rod 52 proximally relative to the sleeve 54 and/or moving the sleeve 54 distally relative to the rod 52 radially expands the frame.
  • the prosthetic valve can also include one or more locking mechanisms that retain the frame in the expanded state.
  • the locking mechanisms can be separate components that are mounted on the frame apart from the actuators, or they can be a sub-component of the actuators themselves.
  • Each rod 52 can include an attachment member 58 along a proximal end portion of the rod 52 configured to form a releasable connection with a corresponding actuator of a delivery apparatus.
  • the actuator(s) of the delivery apparatus can apply forces to the rods for radially compressing or expanding the prosthetic valve 10.
  • the attachment member 58 in the illustrated configuration comprises a notch 60 and a projection 62 that can engage a corresponding projection of an actuator of the delivery apparatus.
  • the prosthetic valve 10 includes three such actuators 50, although a greater or fewer number of actuators could be used in other embodiments.
  • the leaflets 20 can have commissure attachments members 64 that wrap around the sleeves 54 of the actuators 50. Further details of the actuators, locking mechanisms and delivery apparatuses for actuating the actuators can be found in U.S. Patent Application Nos.
  • the frame 12 can be made of any of various suitable materials, such as stainless steel, a cobalt chromium alloy, or a nickel titanium alloy (“NiTi”), for example Nitinol.
  • the frame 12 can include a plurality of interconnected stmts 24 arranged in a lattice-type pattern.
  • the struts 24 are shown as positioned diagonally, or offset at an angle relative to, and radially offset from, a longitudinal axis 26 of the prosthetic valve 10 when the prosthetic valve 10 is in the expanded configuration.
  • the stmts 24 can be offset by a different amount than depicted in FIGS. 2B and 2C, or some or all of the stmts 24 can be positioned parallel to the longitudinal axis 26 of the prosthetic valve 10.
  • the stmts 24 are pivotably coupled to one another at one or more pivot joints along the length of each stmt.
  • the stmts 24 are pivotably coupled to one another at one or more pivot joints along the length of each stmt.
  • each of the stmts 24 can be formed with apertures at opposing ends of the stmt and apertures spaced along the length of the stmt.
  • Respective hinges can be formed at the locations where stmts 24 overlap each other via fasteners, such as rivets or pins 28 that extend through the apertures. The hinges can allow the stmts 24 to pivot relative to one another as the frame 12 is radially expanded or compressed, such as during assembly, preparation, or implantation of the prosthetic valve 10.
  • the stmts 24 are arranged in five rows (I, II, III, IV and V) from the inflow end 14 to the outflow end 16.
  • Each row is defined by the stmt segments extending in a zig-zag pattern between adjacent circumferential rows of hinges 28.
  • the first row I is defined by stmt segments 25 extending between a first row of hinges 28a at the inflow end of the frame and an adjacent row of hinges 28b.
  • segments of the stmts 24 can be arranged in different number of rows.
  • the frame 12 can be constructed by forming individual components (e.g., the stmts and fasteners of the frame) and then mechanically assembling and connecting the individual components together.
  • the stmts 24 are not coupled to each other with respective hinges but are otherwise pivotable or bendable relative to each other to permit radial expansion and contraction of the frame 12.
  • the frame 12 can be formed (e.g., via laser cutting, electroforming or physical vapor deposition) from a single piece of material (e.g., a metal tube). Further details regarding the construction of the frame and the prosthetic valve are described in U.S. Patent Applications Nos.
  • the frame can be made of any of various suitable plastically-expandable materials (e.g., stainless steel, cobalt-chromium alloys, etc.) or self expanding materials (e.g., Nitinol) as known in the art.
  • plastically-expandable materials e.g., stainless steel, cobalt-chromium alloys, etc.
  • self expanding materials e.g., Nitinol
  • the frame (and thus the valve) can be crimped to a radially compressed configuration on a delivery apparatus and then expanded inside a patient by an inflatable balloon or another suitable expansion mechanism.
  • the frame (and thus the valve) can be crimped to a radially compressed
  • valve can be advanced from the delivery sheath, which allows the valve to expand to its functional size.
  • the prosthetic valve 10 can further include an annular skirt 30 that is attached to the frame 12. A flattened view of the skirt 30 is shown in FIG. 8.
  • the skirt 30 in the illustrated embodiment can have an inner portion 32 and an outer portion 34. Specifically, the skirt 30 can extend along an inner surface of the frame 12, around the inflow end 14 of the frame 12, and then along the outer surface of the frame so as to define a fold 36 between the inner portion 32 and outer portion 34.
  • the inner portion 32 can cover at least a portion of an inner surface of the frame 12
  • the outer portion 34 can cover at least a portion of an outer surface of the frame 12.
  • the inner portion 32 of the skirt 30 can function as a sealing member to prevent or decrease paravalvular leakage and to anchor the leaflets 20 to the frame 12.
  • the outer portion 34 of the skirt 30 can function as a sealing member for the prosthetic valve 10 by sealing against the tissue of the native valve annulus and helping to reduce paravalvular leakage past the prosthetic valve 10.
  • the upper edge 38 of the inner portion 32 (which is the outflow edge of the inner portion in the illustrated embodiment) can have an undulating shape that generally follows the shape of a selected row of strut segments 22 of the frame 12 when the frame 12 is in the expanded configuration. In this manner, the upper edge 38 of inner portion 32 can be tightly secured to the selected row of strut segments 22 with sutures.
  • the upper edge 38 of the inner portion 32 can be sutured to row II of stmts segments. In other embodiments, the upper edge 38 of the inner portion 32 can be sutured to row III of stmts segments.
  • the suture(s) used to secure the upper edge 38 extends only around the stmt segments that are aligned with the scallop line defined by the leaflets 20 (the line that tracks the inflow edge portions 21 of the leaflets).
  • the upper edge 38 of the inner portion 32 is“sandwiched” between the frame 12 and the leaflets 20.
  • the inflow edge portions 21 of the leaflets can overlap a portion of the inner surface of the inner portion 32 along the upper edge 38 and the leaflets can be secured to the inner portion 32 with sutures extending through the inner surface of the inner portion 32.
  • the upper edge 40 of the outer portion 34 (which is the outflow edge of the outer portion in the illustrated embodiment) is generally straight and can be attached to the frame at the pivot joints just below row V of stmt segments (see e.g., FIG. 4).
  • the upper edge 40 of the outer portion 34 can also have an undulating shape (similar to the upper edge of the inner portion 32) so that it can be sutured along the stmt segments of a selected row (e.g., row V of stmt segments).
  • the outer portion 34 of the skirt 30 is axially longer than the inner portion 32 of the skirt 30, i.e., the upper edge 40 of the outer portion 34 extends closer to the outflow end 16 of the frame than the upper edge 38 of the inner portion 32.
  • the axial length of the outer portion 34 can be the same as or substantially the same as that of the inner portion 32.
  • the outer portion 34 can be axially shorter than the inner portion 32, i.e., the upper edge 38 of the inner portion 32 can extend closer to the outflow end 16 of the frame than the upper edge 40 of the outer portion 34.
  • the frame 12 is radially expanded to a larger diameter (i.e., the deployment diameter).
  • the deployment diameter can be within a working range of diameters defined between a smallest deployment diameter and a largest deployment diameter. In one exemplary but non-limiting embodiment, the smallest deployment diameter is about 26 mm and the largest deployment diameter is about 29 mm.
  • the outer portion 34 of the skirt 30 when the frame 12 is radially expanded (see e.g., FIGS. 4- 5), the outer portion 34 of the skirt 30 can be slightly stretched in a circumferential direction.
  • the skirt 30 can be sized such that when the frame 12 is expanded to a diameter within the working range, the outer portion 34 of the skirt 30 can be stretched so as to tightly or snugly conform to the outer surface of the frame 12, i.e., no slack is formed in the outer portion 34 around the circumferential periphery of the frame 12.
  • the skirt 30 can be sutured to the frame 12 when it is expanded to its smallest deployment diameter.
  • the skirt 30 can be sized such that the outer portion 34 tightly conforms to the outer surface of the frame 12 without any slack in the radial direction when the frame 12 is expanded to its smallest deployment diameter.
  • Such tight conformation of the skirt 30 on the outer surface of the frame 12 can inhibit the skirt 30 from protruding through the frame cells, thus preventing abrasion of the leaflets 20.
  • the outer portion 34 of the skirt 30 can further tighten on the frame 12.
  • the skirt 30 in order to ensure that the outer portion 34 fits tightly around the frame 12 at its smallest deployment diameter, the skirt 30 can be cut to a smaller size and the skirt 30 can be mounted on the frame 12 (at its smallest deployment diameter) with some stretching in the circumferential direction.
  • the skirt 30 can be sized to fit snugly around the frame without stretching of the skirt in any direction and without any slack in the radial direction when the frame 12 is expanded to its smallest deployment diameter. When the frame is radially expanded to a larger diameter within the working range, the skirt 30 can stretch slightly and tighten around the frame.
  • a prosthetic valve may have only one deployment diameter.
  • the skirt 30 can be sized to fit snugly around the frame without stretching of the skirt in any direction and without any slack in the radial direction when the frame 12 is expanded to the deployment diameter.
  • the skirt 30 can be sized such that it is slightly stretched in the circumferential direction when the frame is expanded to the deployment diameter.
  • the inflow end 14 of the frame 12 can be axially spaced from the fold 36 to form an axially extending gap 42 between the inflow end 14 of frame 12 and the fold 36 (see e.g., FIG. 5).
  • the gap 42 can have a length (L) ranging from about 4 mm to about 8 mm.
  • the length L of the gap 42 can be about 6 mm.
  • the inflow end 14 of the frame 12 can move axially within the gap 42 closer to the fold 36.
  • the inflow end 14 of the frame 12 can extend all the way to the fold 36 such that the frame 12 completely fills the gap 42.
  • the outer portion 34 of the skirt 30 can form longitudinal pleats as illustrated in FIG. 3. Meanwhile, the inner portion 32 of the skirt 30 can fold inwardly toward the interior of the frame 12.
  • the skirt 30 can be formed from any of various suitable biocompatible materials, including any of various synthetic materials (e.g., PET) or natural tissue (e.g., pericardial tissue).
  • the skirt 30 is generally non-elastic.
  • the skirt 30 can be woven using PET fibers or yarns in both the warp (longitudinal) and weft
  • the skirt can be assembled on the frame such that the warp fibers extend in the axial direction of the frame and the weft fibers extend in the circumferential direction of the frame.
  • the skirt can be assembled on the frame such that the weft fibers extend in the axial direction of the frame and the warp fibers extend in the circumferential direction of the frame.
  • the skirt 30 can be elongated in both the radial and axial directions to certain degrees even if it is still woven using non-elastic fibers. Such pseudo elasticity can be achieved, for example, by orienting the fibers at angles relative to the height of the skirt and/or increasing the spacing between fibers.
  • the skirt 30 can be woven from a first set of fibers (or yarns or strands) extending in a first direction 44, and a second set of fibers (or yams or strands) extending in a second direction 46, wherein neither the first direction 44 nor the second direction 46 being perpendicular to the fold 36.
  • the first direction 44 can be generally perpendicular to the second direction 46, and the second direction can extend at an angle a of about 45 degrees (e.g., between 15-75 degrees or between 30-60 degrees) relative to the fold 36.
  • the first direction 44 extends parallel or substantially parallel to outer struts 24a and the second direction 46 extends parallel or substantially parallel to inner stmts 24b when the frame 12 is in its radially expanded state.
  • the spacing between the woven fibers (or yarns or strands) can be increased to facilitate elongation of the skirt 30 in both radial and axial directions.
  • the yam density can be about 15% to about 30% less than a conventional PET skirt.
  • the yarn spacing of the skirt 30 can be from about 155 yarns per inch to about 180 yarns per inch, such as about 160 yams per inch, whereas in a conventional PET skirt the yarn spacing can be from about 217 yams per inch to about 247 yams per inch.
  • the fibers can be oriented so that they are parallel or substantially parallel to the stmts and/or increasing the spacing between the fibers can allow the skirt 30 to elongate in the axial and/or circumferential direction by up to about 40%.
  • rotation of the fibers and/or increasing the spacing between the fibers can allow the skirt 30 to elongate in the circumferential direction from the smallest deployment diameter up to the largest deployment diameter.
  • the outer portion 34 of the skirt 30 does not constrain axial elongation of the frame 12 when the frame is radially compressed.
  • the frame 12 is free to move axially within the axially extending gap 42 toward the fold 36 during crimping. Consequently, relatively low crimping forces are needed to crimp the prosthetic valve 10 and overstretching of the skirt 30 can be avoided.
  • a tether 48 can be coupled to the skirt 30 to prevent the fold 36 from moving inside the frame 12 when the frame 12 is radially expanded from the
  • the skirt 30 can include a tether 48 extending diagonally from a first end 48a to a second end 48b located at or near the fold 36 such that the tether 48 forms an oblique angle relative to the fold 36 (see e.g., FIG. 3).
  • the angle between the tether 48 and the fold 36 can range from about 10° to about 80°.
  • the angle between the tether 48 and the fold 36 can range from about 30° to about 60°. In one specific embodiment, the angle between the tether 48 and the fold 36 can be about 45°.
  • the first end 48a can be located at the upper edge 40 of the outer portion 34. In another embodiment, the first 48a can be spaced from the upper edge 40. In alternative embodiments, the first end 48a can be attached to an upper portion of the frame 12. In some embodiments (not shown), more than one tether 48 can be coupled to the skirt 30, with each tether 48 extending at an oblique angle relative to the fold 36.
  • the tether 48 can be formed from a suture that is stitched to the outer portion 34 of the skirt using, for example, in-and-out stitches, as depicted in FIGS. 3 and 4. Due to the in-and-out stitches, the length of the suture can be longer than the distance traveled by the suture such that the suture line can be elongated if stretched. In this manner, the suture can function similar to a coil, which returns to its original length after being stretched.
  • the tether 48 can be formed from an elastic material (e.g., an elastic fabric) that can be stretched longitudinally when tension is applied along its length and then return to its original length when tension is removed.
  • the tether 48 when the frame 12 is radially expanded from the compressed configuration to the expanded configuration, the tether 48 can be stretched in the lengthwise direction of the tether due to radial expansion of the outer portion 34 of the skirt. As a result, the tether 48 is relatively taut and can hold the fold 36 in place against hemodynamic forces. Thus, the tether 48 can prevent the fold 36 from moving inside the frame 12 when the frame 12 is in the expanded configuration, which may otherwise obstruct the fluid inflow through the valve 10. When the frame 12 is radially compressed, the tether 48 can return to its original length.
  • the prosthetic valve 10 described above can be mounted on a delivery apparatus and delivered to a target location within the patient.
  • Various embodiments of the delivery apparatus and methods of delivering the prosthetic valve have been described, e.g., in U.S. Patent Application Publication Nos. 2013/0030519, 2010/0049313, 2009/0281619,
  • the prosthetic valve 10 can be crimped onto a shaft of the delivery apparatus.
  • the diameter of the frame 12 decreases while the axial length of the frame 12 elongates.
  • the skirt 30 can elongate in the axial direction.
  • the frame 12 is not constrained by the outer portion 34 of the skirt 30, the frame 12 is free to elongate in the axial direction and the inflow end 14 of the frame 12 can extend into the gap 42 during crimping.
  • the outer portion 34 of the skirt 30 can form longitudinal pleats and the inner portion 32 of the skirt 30 can fold inwardly.
  • the prosthetic valve 10 After being delivered to the target location, the prosthetic valve 10 can be expanded until the diameter of the frame 12 is within its working range. During expansion, the diameter of the frame 12 increases while the axial length of the frame 12 shortens. When the prosthetic valve 10 is in the radially expanded configuration, the outer portion 34 of the skirt 30 in particular embodiments can be stretched circumferentially such that it can tightly conform to the outer surface of the frame 12 without any slack in the radial direction.
  • the inflow end 14 of the frame 12 can move away from the fold 36 to form an axially extending gap 42 between the frame 12 and the fold 36.
  • one or more tethers 48 can be coupled to the skirt 30 to prevent the fold 36 from moving inside the frame 12 during valve expansion.
  • FIG. 9 shows a prosthetic valve 110, according to another embodiment.
  • the prosthetic valve 110 includes a frame 112 that can be radially expandable and compressible between a radially compressed configuration and a radially expanded configuration. Similar to the prosthetic valve 10, the prosthetic valve 110 can include a valvular structure 118 attached to the frame 112, and the valvular structure 118 can include a plurality of leaflets 120 having scalloped geometry (three leaflets are shown in FIG. 9).
  • the prosthetic valve 110 can further include an outer skirt 130 that covers at least a portion of the outer surface of the frame 112.
  • the lower edge 136 of the skirt 130 (the inflow edge in the illustrated embodiment) can extend from the inflow end 114 of the frame 112, whereas an upper edge 140 of the skirt 130 (the outflow edge in the illustrated embodiment) can be offset from an outflow end 116 of the frame 112.
  • the frame 112 has five rows of strut segments, and only the row of stmt segments defining the outflow end 116 is not covered by the skirt 130.
  • the skirt 130 can be sized to cover a different portion of the outer surface of the frame than shown in FIG. 9 or it can extend over the entire outer surface of the frame 112. In some embodiments, the skirt 130 can fold around the inflow end 114 of the frame to form a gap similar to the axially extending gap 42 depicted in FIG. 5.
  • the skirt 130 can be sutured to the stmt segments 124 of the frame 112 along the scallop line 121 defined by the inflow edges of the leaflets 120.
  • the scallop line 121 is a zig-zag shaped attachment line for the skirt 130 and the inflow edges of the leaflets 120.
  • the sutures 122 can be positioned to wrap around a plurality of stmts so that the sutures 122 are positioned along a path that generally follows the scallop line 121. As shown in FIG.
  • each segment of the scallop line 121 (where the inflow edges of the leaflets 120 attach to the frame 112) forms an approximately 45-degree angle relative to the longitudinal axis 126 of the frame 112 when the frame 112 is in the expanded configuration.
  • the stmt segments along the scallop line 121 move inwardly.
  • those suture 122 along the scallop lines 121 do not impose stress to the skirt 130.
  • some of the sutures 122 along the scallop line 121 are configured to be slidable along the struts. Such sliding sutures can further reduce the stress to the skirt 130 when the frame 112 is radially compressed or expanded.
  • the outer skirt 130 is connected to the frame only along the attachment line 121; that is, the outer skirt is not connected to any struts of the frame or other components of the prosthetic valve at locations not along the attachment line 121.
  • the outer skirt 130 is connected to the struts of the frame along the attachment line 121, while the inflow edge portions of the leaflets 120 need not be connected to the frame along the attachment line 121.
  • FIG. 10 shows a prosthetic valve 210, according to another embodiment. Similar to the valve 110 discussed above, the valve 210 includes a radially compressible and expandable frame 212 and an outer skirt 230 covering at least a portion of the outer surface of the frame 212. Like valve 110, the skirt 230 can be secured to the frame 212 with sutures 222 along a predefined scallop line 221 (which is a zig-zag shaped attachment line for the skirt in the illustrated embodiment). The valvular structure is not shown in FIG. 10 so that the suture lines 221 in the back of the frame 212 can be clearly seen. The frame 212 in the illustrated embodiment has four rows of strut segments, and the two rows of strut segments closest to near the outflow end 216 are not covered by the skirt 230.
  • the fabric of skirt 130 or 230 can be woven using non-elastic fibers that are rotated (e.g., 45 degrees), and optionally with increased spacing between fibers, so that the skirt 130 or 230 can accommodate certain degree of elongation in both radial and axial directions.
  • the skirt 130 or 230 can be sized such it tightly conforms to the outer surface of the respective frame 112 or 212 without any slack when the respective frame 112 or 212 is expanded to its smallest working diameter.
  • Fig. 12A shows that when the frame 112 is radially compressed, portions of the skirt 130 can billow out to form V-shaped, longitudinally extending folded flaps 150 between adjacent sections of the scallop-shaped suture line 121.
  • each flap 150 can be further folded in a circumferential direction so as to maintain a low crimping profile of the valve 110.
  • each flap 150 can partially overlap an adjacent flap in a circumferential direction.
  • FIGS. 12B- 12C show that the flaps 150 are folded in a clockwise direction (viewed from the outflow end), although it should be understood that the flaps 150 can also be folded in a counter clockwise direction.
  • the skirt 230 can billow out to form V-shaped, longitudinally extending folded flaps 250 between adjacent sections of the suture line 221.
  • the inflow and outflow edges of the skirt 130 and skirt 230 are not connected to the frame or other components of the prosthetic valve except along the attachment line 121, 221 which forms a plurality of first V-shaped flaps opening toward the outflow end of the prosthetic valve alternating with a plurality of second V-shaped flaps opening toward the inflow end of the prosthetic valve around a circumference of the frame (as best shown in FIG. 11).
  • the disclosed embodiments can be adapted to deliver and implant prosthetic devices in any of the native annuluses of the heart (e.g., the pulmonary, mitral, and tricuspid annuluses), and can be used with any of various delivery approaches (e.g., retrograde, antegrade, transseptal, transventricular, transatrial, etc.).
  • native annuluses of the heart e.g., the pulmonary, mitral, and tricuspid annuluses
  • delivery approaches e.g., retrograde, antegrade, transseptal, transventricular, transatrial, etc.
  • the singular forms“a,”“an,” and“the” include the plural forms unless the context clearly dictates otherwise.
  • the term “includes” means“comprises.”
  • the terms“coupled” and“connected” generally mean electrically, electromagnetically, and/or physically (e.g., mechanically or chemically) coupled or linked and does not exclude the presence of intermediate elements between the coupled or associated items absent specific contrary language.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Prostheses (AREA)
PCT/US2020/014701 2019-01-28 2020-01-23 Prosthetic valve Ceased WO2020159783A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EP25161107.5A EP4541318A3 (en) 2019-01-28 2020-01-23 Prosthetic valve
JP2021543425A JP7662526B2 (ja) 2019-01-28 2020-01-23 補綴弁
CN202080020800.3A CN113613594B (zh) 2019-01-28 2020-01-23 假体瓣膜
EP20706922.0A EP3917453B1 (en) 2019-01-28 2020-01-23 Prosthetic valve
CN202411580053.5A CN119857008A (zh) 2019-01-28 2020-01-23 假体瓣膜
US17/359,964 US12201519B2 (en) 2019-01-28 2021-06-28 Prosthetic valve
US18/969,583 US20250090318A1 (en) 2019-01-28 2024-12-05 Prosthetic valve
US19/029,188 US20250169947A1 (en) 2019-01-28 2025-01-17 Prosthetic valve
JP2025061263A JP2025096362A (ja) 2019-01-28 2025-04-02 補綴弁

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962797837P 2019-01-28 2019-01-28
US62/797,837 2019-01-28

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/359,964 Continuation US12201519B2 (en) 2019-01-28 2021-06-28 Prosthetic valve

Publications (1)

Publication Number Publication Date
WO2020159783A1 true WO2020159783A1 (en) 2020-08-06

Family

ID=69650752

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2020/014701 Ceased WO2020159783A1 (en) 2019-01-28 2020-01-23 Prosthetic valve

Country Status (5)

Country Link
US (3) US12201519B2 (enExample)
EP (2) EP4541318A3 (enExample)
JP (2) JP7662526B2 (enExample)
CN (2) CN113613594B (enExample)
WO (1) WO2020159783A1 (enExample)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021141878A1 (en) 2020-01-10 2021-07-15 Edwards Lifesciences Corporation Assembly methods for a prosthetic heart valve leaflet
WO2021188609A2 (en) 2020-03-17 2021-09-23 Edwards Lifesciences Corporation Modification of existing valvular structures for prosthetic heart valve implantation
WO2021242952A1 (en) 2020-05-28 2021-12-02 Edwards Lifesciences Corporation Methods and devices for leaflet folding or capture
WO2022076508A1 (en) * 2020-10-06 2022-04-14 Edwards Lifesciences Corporation Protective covers for prosthetic valves
WO2022103845A1 (en) 2020-11-11 2022-05-19 Edwards Lifesciences Corporation Prosthetic heart valves with sealing frames to reduce paravalvular leakage
WO2022103747A1 (en) 2020-11-10 2022-05-19 Edwards Lifesciences Corporation Prosthetic heart valves with hermetic layers or valvular structures to reduce thrombosis risk
WO2022226150A1 (en) 2021-04-22 2022-10-27 Edwards Lifesciences Corporation Prosthetic heart valves with ratcheting lock mechanisms, and methods for fabrication and use
WO2025101895A1 (en) 2023-11-09 2025-05-15 Edwards Lifesciences Corporation Percutaneous valve leaflet modification

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN216823784U (zh) * 2020-07-10 2022-06-28 爱德华兹生命科学公司 假体瓣膜和递送组件
EP4429598A1 (en) * 2021-11-13 2024-09-18 Edwards Lifesciences Corporation Prosthetic heart valves with releasably attached outer skirts and methods associated therewith
WO2024155516A1 (en) * 2023-01-19 2024-07-25 Edwards Lifesciences Corporation Sealing skirts for prosthetic heart valves
WO2025221671A1 (en) * 2024-04-17 2025-10-23 Edwards Lifesciences Corporation Prosthetic heart valve

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730118B2 (en) 2001-10-11 2004-05-04 Percutaneous Valve Technologies, Inc. Implantable prosthetic valve
US20070005131A1 (en) 2005-06-13 2007-01-04 Taylor David M Heart valve delivery system
US20080065011A1 (en) 2006-09-08 2008-03-13 Philippe Marchand Integrated heart valve delivery system
US20090281619A1 (en) 2008-05-09 2009-11-12 Edwards Lifesciences Corporation Low Profile Delivery System for Transcatheter Heart Valve
US20100049313A1 (en) 2008-08-22 2010-02-25 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
US7993394B2 (en) 2008-06-06 2011-08-09 Ilia Hariton Low profile transcatheter heart valve
WO2012048035A2 (en) * 2010-10-05 2012-04-12 Edwards Lifesciences Corporation Prosthetic heart valve
US20130030519A1 (en) 2011-07-27 2013-01-31 Edwards Lifesciences Corporation Delivery systems for prosthetic heart valve
US20140296962A1 (en) 2011-10-21 2014-10-02 Syntheon Cardiology, Llc Actively Controllable Stent, Stent Graft, Heart Valve and Method of Controlling Same
US20150135506A1 (en) 2013-11-11 2015-05-21 Jenesis Surgical, Llc Systems and methods for manufacturing a stent frame
US20160317305A1 (en) * 2015-04-29 2016-11-03 Edwards Lifesciences Corporation Laminated sealing member for prosthetic heart valve
US20170065408A1 (en) * 2014-05-06 2017-03-09 Dsm Ip Assets B.V. Method of making a prosthetic valve and valve obtained therewith
US20180133003A1 (en) * 2016-11-17 2018-05-17 Edwards Lifesciences Corporation Prosthetic heart valve having leaflet inflow below frame
US20180153689A1 (en) 2016-12-06 2018-06-07 Edwards Lifesciences Corporation Mechanically expanding heart valve and delivery apparatus therefor

Family Cites Families (305)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1127325A (en) 1965-08-23 1968-09-18 Henry Berry Improved instrument for inserting artificial heart valves
US3587115A (en) 1966-05-04 1971-06-28 Donald P Shiley Prosthetic sutureless heart valves and implant tools therefor
US3548417A (en) 1967-09-05 1970-12-22 Ronnie G Kischer Heart valve having a flexible wall which rotates between open and closed positions
USRE30912E (en) 1968-09-16 1982-04-27 Hancock Laboratories, Inc. Stent for heart valve
US3671979A (en) 1969-09-23 1972-06-27 Univ Utah Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US3714671A (en) 1970-11-30 1973-02-06 Cutter Lab Tissue-type heart valve with a graft support ring or stent
US3755823A (en) 1971-04-23 1973-09-04 Hancock Laboratories Inc Flexible stent for heart valve
GB1402255A (en) 1971-09-24 1975-08-06 Smiths Industries Ltd Medical or surgical devices of the kind having an inflatable balloon
US4035849A (en) 1975-11-17 1977-07-19 William W. Angell Heart valve stent and process for preparing a stented heart valve prosthesis
CA1069652A (en) 1976-01-09 1980-01-15 Alain F. Carpentier Supported bioprosthetic heart valve with compliant orifice ring
US4056854A (en) 1976-09-28 1977-11-08 The United States Of America As Represented By The Department Of Health, Education And Welfare Aortic heart valve catheter
US4297749A (en) 1977-04-25 1981-11-03 Albany International Corp. Heart valve prosthesis
US4222126A (en) 1978-12-14 1980-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health, Education & Welfare Unitized three leaflet heart valve
US4265694A (en) 1978-12-14 1981-05-05 The United States Of America As Represented By The Department Of Health, Education And Welfare Method of making unitized three leaflet heart valve
US4574803A (en) 1979-01-19 1986-03-11 Karl Storz Tissue cutter
GB2056023B (en) 1979-08-06 1983-08-10 Ross D N Bodnar E Stent for a cardiac valve
US4373216A (en) 1980-10-27 1983-02-15 Hemex, Inc. Heart valves having edge-guided occluders
US4388735A (en) 1980-11-03 1983-06-21 Shiley Inc. Low profile prosthetic xenograft heart valve
US4339831A (en) 1981-03-27 1982-07-20 Medtronic, Inc. Dynamic annulus heart valve and reconstruction ring
US4470157A (en) 1981-04-27 1984-09-11 Love Jack W Tricuspid prosthetic tissue heart valve
US4345340A (en) 1981-05-07 1982-08-24 Vascor, Inc. Stent for mitral/tricuspid heart valve
US4406022A (en) 1981-11-16 1983-09-27 Kathryn Roy Prosthetic valve means for cardiovascular surgery
SE445884B (sv) 1982-04-30 1986-07-28 Medinvent Sa Anordning for implantation av en rorformig protes
IT1212547B (it) 1982-08-09 1989-11-30 Iorio Domenico Strumento di impiego chirurgico destinato a rendere piu' facili e piu' sicuri gli interventi per l'impianto di bioprotesi in organi umani
GB8300636D0 (en) 1983-01-11 1983-02-09 Black M M Heart valve replacements
US4535483A (en) 1983-01-17 1985-08-20 Hemex, Inc. Suture rings for heart valves
US4612011A (en) 1983-07-22 1986-09-16 Hans Kautzky Central occluder semi-biological heart valve
US4787899A (en) 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US4627436A (en) 1984-03-01 1986-12-09 Innoventions Biomedical Inc. Angioplasty catheter and method for use thereof
US4592340A (en) 1984-05-02 1986-06-03 Boyles Paul W Artificial catheter means
US4979939A (en) 1984-05-14 1990-12-25 Surgical Systems & Instruments, Inc. Atherectomy system with a guide wire
US5007896A (en) 1988-12-19 1991-04-16 Surgical Systems & Instruments, Inc. Rotary-catheter for atherectomy
US4883458A (en) 1987-02-24 1989-11-28 Surgical Systems & Instruments, Inc. Atherectomy system and method of using the same
DE3426300A1 (de) 1984-07-17 1986-01-30 Doguhan Dr.med. 6000 Frankfurt Baykut Zweiwegeventil und seine verwendung als herzklappenprothese
DE3442088A1 (de) 1984-11-17 1986-05-28 Beiersdorf Ag, 2000 Hamburg Herzklappenprothese
SU1271508A1 (ru) 1984-11-29 1986-11-23 Горьковский государственный медицинский институт им.С.М.Кирова Искусственный клапан сердца
US4759758A (en) 1984-12-07 1988-07-26 Shlomo Gabbay Prosthetic heart valve
FR2587614B1 (fr) 1985-09-23 1988-01-15 Biomasys Sa Valve cardiaque prothetique
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
DE3640745A1 (de) 1985-11-30 1987-06-04 Ernst Peter Prof Dr M Strecker Katheter zum herstellen oder erweitern von verbindungen zu oder zwischen koerperhohlraeumen
CH672247A5 (enExample) 1986-03-06 1989-11-15 Mo Vysshee Tekhnicheskoe Uchil
US4878906A (en) 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US4777951A (en) 1986-09-19 1988-10-18 Mansfield Scientific, Inc. Procedure and catheter instrument for treating patients for aortic stenosis
US4762128A (en) 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4878495A (en) 1987-05-15 1989-11-07 Joseph Grayzel Valvuloplasty device with satellite expansion means
US4796629A (en) 1987-06-03 1989-01-10 Joseph Grayzel Stiffened dilation balloon catheter device
US4829990A (en) 1987-06-25 1989-05-16 Thueroff Joachim Implantable hydraulic penile erector
US4851001A (en) 1987-09-17 1989-07-25 Taheri Syde A Prosthetic valve for a blood vein and an associated method of implantation of the valve
US5266073A (en) 1987-12-08 1993-11-30 Wall W Henry Angioplasty stent
US5032128A (en) 1988-07-07 1991-07-16 Medtronic, Inc. Heart valve prosthesis
DE8815082U1 (de) 1988-11-29 1989-05-18 Biotronik Meß- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin, 1000 Berlin Herzklappenprothese
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US4966604A (en) 1989-01-23 1990-10-30 Interventional Technologies Inc. Expandable atherectomy cutter with flexibly bowed blades
US4994077A (en) 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
DE69016426T2 (de) 1989-05-31 1995-08-17 Baxter Int Biologische klappenprothese.
US5609626A (en) 1989-05-31 1997-03-11 Baxter International Inc. Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts
US5047041A (en) 1989-08-22 1991-09-10 Samuels Peter B Surgical apparatus for the excision of vein valves in situ
US4986830A (en) 1989-09-22 1991-01-22 Schneider (U.S.A.) Inc. Valvuloplasty catheter with balloon which remains stable during inflation
US5089015A (en) 1989-11-28 1992-02-18 Promedica International Method for implanting unstented xenografts and allografts
US5591185A (en) 1989-12-14 1997-01-07 Corneal Contouring Development L.L.C. Method and apparatus for reprofiling or smoothing the anterior or stromal cornea by scraping
US5037434A (en) 1990-04-11 1991-08-06 Carbomedics, Inc. Bioprosthetic heart valve with elastic commissures
US5059177A (en) 1990-04-19 1991-10-22 Cordis Corporation Triple lumen balloon catheter
DK124690D0 (da) 1990-05-18 1990-05-18 Henning Rud Andersen Klapprotes til implantering i kroppen for erstatning af naturlig klap samt kateter til brug ved implantering af en saadan klapprotese
US5411552A (en) 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5085635A (en) 1990-05-18 1992-02-04 Cragg Andrew H Valved-tip angiographic catheter
US5152771A (en) 1990-12-31 1992-10-06 The Board Of Supervisors Of Louisiana State University Valve cutter for arterial by-pass surgery
US5282847A (en) 1991-02-28 1994-02-01 Medtronic, Inc. Prosthetic vascular grafts with a pleated structure
JPH05184611A (ja) 1991-03-19 1993-07-27 Kenji Kusuhara 弁輪支持器具及びその取り付け方法
US5295958A (en) 1991-04-04 1994-03-22 Shturman Cardiology Systems, Inc. Method and apparatus for in vivo heart valve decalcification
US5167628A (en) 1991-05-02 1992-12-01 Boyles Paul W Aortic balloon catheter assembly for indirect infusion of the coronary arteries
US5397351A (en) 1991-05-13 1995-03-14 Pavcnik; Dusan Prosthetic valve for percutaneous insertion
US5584803A (en) 1991-07-16 1996-12-17 Heartport, Inc. System for cardiac procedures
US5558644A (en) 1991-07-16 1996-09-24 Heartport, Inc. Retrograde delivery catheter and method for inducing cardioplegic arrest
US5769812A (en) 1991-07-16 1998-06-23 Heartport, Inc. System for cardiac procedures
US5370685A (en) 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
US5192297A (en) 1991-12-31 1993-03-09 Medtronic, Inc. Apparatus and method for placement and implantation of a stent
US5756476A (en) 1992-01-14 1998-05-26 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of cell proliferation using antisense oligonucleotides
US5163953A (en) 1992-02-10 1992-11-17 Vince Dennis J Toroidal artificial heart valve stent
US5683448A (en) 1992-02-21 1997-11-04 Boston Scientific Technology, Inc. Intraluminal stent and graft
US5628792A (en) 1992-03-13 1997-05-13 Jcl Technic Ab Cardiac valve with recessed valve flap hinges
US5332402A (en) 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
DE4327825C2 (de) 1992-11-24 1996-10-02 Mannesmann Ag Drosselrückschlagelement
US6346074B1 (en) 1993-02-22 2002-02-12 Heartport, Inc. Devices for less invasive intracardiac interventions
GB9312666D0 (en) 1993-06-18 1993-08-04 Vesely Ivan Bioprostetic heart valve
CA2125258C (en) 1993-08-05 1998-12-22 Dinah B Quiachon Multicapsule intraluminal grafting system and method
US5545209A (en) 1993-09-30 1996-08-13 Texas Petrodet, Inc. Controlled deployment of a medical device
US5480424A (en) 1993-11-01 1996-01-02 Cox; James L. Heart valve replacement using flexible tubes
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5728068A (en) 1994-06-14 1998-03-17 Cordis Corporation Multi-purpose balloon catheter
US5554185A (en) 1994-07-18 1996-09-10 Block; Peter C. Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same
US5639274A (en) 1995-06-02 1997-06-17 Fischell; Robert E. Integrated catheter system for balloon angioplasty and stent delivery
US5716417A (en) 1995-06-07 1998-02-10 St. Jude Medical, Inc. Integral supporting structure for bioprosthetic heart valve
US5571175A (en) 1995-06-07 1996-11-05 St. Jude Medical, Inc. Suture guard for prosthetic heart valve
DE19532846A1 (de) 1995-09-06 1997-03-13 Georg Dr Berg Ventileinrichtung
US5591195A (en) 1995-10-30 1997-01-07 Taheri; Syde Apparatus and method for engrafting a blood vessel
DE19546692C2 (de) 1995-12-14 2002-11-07 Hans-Reiner Figulla Selbstexpandierende Herzklappenprothese zur Implantation im menschlichen Körper über ein Kathetersystem
FR2742994B1 (fr) 1995-12-28 1998-04-03 Sgro Jean-Claude Ensemble de traitement chirurgical d'une lumiere intracorporelle
US5855602A (en) 1996-09-09 1999-01-05 Shelhigh, Inc. Heart valve prosthesis
EP0808614B1 (en) 1996-05-23 2003-02-26 Samsung Electronics Co., Ltd. Flexible self-expandable stent and method for making the same
US5855601A (en) 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US6217585B1 (en) 1996-08-16 2001-04-17 Converge Medical, Inc. Mechanical stent and graft delivery system
US5749890A (en) 1996-12-03 1998-05-12 Shaknovich; Alexander Method and system for stent placement in ostial lesions
NL1004827C2 (nl) 1996-12-18 1998-06-19 Surgical Innovations Vof Inrichting voor het reguleren van de bloedsomloop.
EP0850607A1 (en) 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
GB9701479D0 (en) 1997-01-24 1997-03-12 Aortech Europ Ltd Heart valve
US5957949A (en) 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6206917B1 (en) 1997-05-02 2001-03-27 St. Jude Medical, Inc. Differential treatment of prosthetic devices
US5855597A (en) 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US6245102B1 (en) 1997-05-07 2001-06-12 Iowa-India Investments Company Ltd. Stent, stent graft and stent valve
US5925063A (en) 1997-09-26 1999-07-20 Khosravi; Farhad Coiled sheet valve, filter or occlusive device and methods of use
US6769161B2 (en) 1997-10-16 2004-08-03 Scimed Life Systems, Inc. Radial stent crimper
US5910170A (en) 1997-12-17 1999-06-08 St. Jude Medical, Inc. Prosthetic heart valve stent utilizing mounting clips
US6530952B2 (en) 1997-12-29 2003-03-11 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
EP2258312B9 (en) 1997-12-29 2012-09-19 The Cleveland Clinic Foundation Deployable surgical platform and system for the removal and delivery of a medical device comprising such deployable surgical platform
EP0935978A1 (en) 1998-02-16 1999-08-18 Medicorp S.A. Angioplasty and stent delivery catheter
US6174327B1 (en) 1998-02-27 2001-01-16 Scimed Life Systems, Inc. Stent deployment apparatus and method
EP0943300A1 (en) 1998-03-17 1999-09-22 Medicorp S.A. Reversible action endoprosthesis delivery device.
US6527979B2 (en) 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
US6334873B1 (en) 1998-09-28 2002-01-01 Autogenics Heart valve having tissue retention with anchors and an outer sheath
DE19857887B4 (de) 1998-12-15 2005-05-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verankerungsstütze für eine Herzklappenprothese
SG76636A1 (en) 1998-12-22 2000-11-21 Medinol Ltd Apparatus and method for securing a stent on a balloon
FR2788217A1 (fr) 1999-01-12 2000-07-13 Brice Letac Valvule prothetique implantable par catheterisme, ou chirurgicalement
US6350277B1 (en) 1999-01-15 2002-02-26 Scimed Life Systems, Inc. Stents with temporary retaining bands
US6338740B1 (en) 1999-01-26 2002-01-15 Edwards Lifesciences Corporation Flexible heart valve leaflets
US6896690B1 (en) 2000-01-27 2005-05-24 Viacor, Inc. Cardiac valve procedure methods and devices
US6425916B1 (en) 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
DE19907646A1 (de) 1999-02-23 2000-08-24 Georg Berg Ventileinrichtung zum Einsetzen in ein Hohlorgan
US6210408B1 (en) 1999-02-24 2001-04-03 Scimed Life Systems, Inc. Guide wire system for RF recanalization of vascular blockages
US6231602B1 (en) 1999-04-16 2001-05-15 Edwards Lifesciences Corporation Aortic annuloplasty ring
BR0010096A (pt) 1999-04-28 2002-02-19 St Jude Medical Prótese valvular cardìaca, kit, processo para ligar uma prótese valvular cardìaca em um paciente, e, aplicador prendedor para implantar uma prótese valvular cardìaca
EP1057460A1 (en) 1999-06-01 2000-12-06 Numed, Inc. Replacement valve assembly and method of implanting same
US7628803B2 (en) 2001-02-05 2009-12-08 Cook Incorporated Implantable vascular device
US6299637B1 (en) 1999-08-20 2001-10-09 Samuel M. Shaolian Transluminally implantable venous valve
US6352547B1 (en) 1999-09-22 2002-03-05 Scimed Life Systems, Inc. Stent crimping system
IT1307268B1 (it) 1999-09-30 2001-10-30 Sorin Biomedica Cardio Spa Dispositivo per interventi di riparazione o sostituzione valvolarecardiaca.
US6689150B1 (en) 1999-10-27 2004-02-10 Atritech, Inc. Filter apparatus for ostium of left atrial appendage
FR2800984B1 (fr) 1999-11-17 2001-12-14 Jacques Seguin Dispositif de remplacement d'une valve cardiaque par voie percutanee
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
FR2815844B1 (fr) 2000-10-31 2003-01-17 Jacques Seguin Support tubulaire de mise en place, par voie percutanee, d'une valve cardiaque de remplacement
DE19955490A1 (de) 1999-11-18 2001-06-13 Thermamed Gmbh Medizintechnische Wärmevorrichtung
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
DE60134625D1 (de) 2000-01-27 2008-08-14 3F Therapeutics Inc Herzklappenprothese
PL201632B1 (pl) 2000-01-31 2009-04-30 Cook Biotech Zespół zastawki stentu
DE10010073B4 (de) 2000-02-28 2005-12-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verankerung für implantierbare Herzklappenprothesen
DE10010074B4 (de) 2000-02-28 2005-04-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Vorrichtung zur Befestigung und Verankerung von Herzklappenprothesen
US6454799B1 (en) 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
WO2002022054A1 (en) 2000-09-12 2002-03-21 Gabbay S Valvular prosthesis and method of using same
US7510572B2 (en) 2000-09-12 2009-03-31 Shlomo Gabbay Implantation system for delivery of a heart valve prosthesis
US6461382B1 (en) 2000-09-22 2002-10-08 Edwards Lifesciences Corporation Flexible heart valve having moveable commissures
DE10047614C2 (de) 2000-09-26 2003-03-27 Generis Gmbh Vorrichtung zum schichtweisen Aufbau von Modellen
DE10049812B4 (de) 2000-10-09 2004-06-03 Universitätsklinikum Freiburg Vorrichtung zum Ausfiltern makroskopischer Teilchen aus der Blutbahn beim lokalen Abtrag einer Aortenklappe am menschlichen oder tierischen Herz
DE10049815B4 (de) 2000-10-09 2005-10-13 Universitätsklinikum Freiburg Vorrichtung zum lokalen Abtrag einer Aortenklappe am menschlichen oder tierischen Herz
DE10049813C1 (de) 2000-10-09 2002-04-18 Universitaetsklinikum Freiburg Vorrichtung zum lokalen Abtrag einer Aortenklappe am menschlichen oder tierischen Herz
DE10049814B4 (de) 2000-10-09 2006-10-19 Universitätsklinikum Freiburg Vorrichtung zur Unterstützung chirurgischer Maßnahmen innerhalb eines Gefäßes, insbesondere zur minimalinvasiven Explantation und Implantation von Herzklappen
US6482228B1 (en) 2000-11-14 2002-11-19 Troy R. Norred Percutaneous aortic valve replacement
ES2247198T3 (es) 2000-11-21 2006-03-01 Rex Medical, Lp Valvula aortica percutanea.
US6440764B1 (en) 2000-11-22 2002-08-27 Agere Systems Guardian Corp. Enhancement of carrier concentration in As-containing contact layers
US6494909B2 (en) 2000-12-01 2002-12-17 Prodesco, Inc. Endovascular valve
DE60115280T2 (de) 2000-12-15 2006-08-10 Angiomed Gmbh & Co. Medizintechnik Kg Stent mit herzklappe
US6716244B2 (en) 2000-12-20 2004-04-06 Carbomedics, Inc. Sewing cuff assembly for heart valves
US6468660B2 (en) 2000-12-29 2002-10-22 St. Jude Medical, Inc. Biocompatible adhesives
US6783542B2 (en) 2001-02-22 2004-08-31 Scimed Life Systems, Inc Crimpable balloon/stent protector
US6488704B1 (en) 2001-05-07 2002-12-03 Biomed Solutions, Llc Implantable particle measuring apparatus
US6503272B2 (en) 2001-03-21 2003-01-07 Cordis Corporation Stent-based venous valves
US6733525B2 (en) 2001-03-23 2004-05-11 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of use
US7556646B2 (en) 2001-09-13 2009-07-07 Edwards Lifesciences Corporation Methods and apparatuses for deploying minimally-invasive heart valves
US7374571B2 (en) 2001-03-23 2008-05-20 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of manufacture
DE60209583T2 (de) 2001-03-30 2006-12-21 Terumo K.K. Stent
WO2002087474A1 (en) 2001-05-01 2002-11-07 Imperial Medical Devices Limited Valve prosthesis
US6936067B2 (en) 2001-05-17 2005-08-30 St. Jude Medical Inc. Prosthetic heart valve with slit stent
WO2003018100A1 (en) 2001-08-22 2003-03-06 Hasan Semih Oktay Flexible mems actuated controlled expansion stent
WO2003043676A2 (en) 2001-11-23 2003-05-30 Mindguard Ltd. Expandable delivery appliance particularly for delivering intravascular devices
US7182779B2 (en) 2001-12-03 2007-02-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US7141064B2 (en) 2002-05-08 2006-11-28 Edwards Lifesciences Corporation Compressed tissue for heart valve leaflets
US20040024452A1 (en) 2002-08-02 2004-02-05 Kruse Steven D. Valved prostheses with preformed tissue leaflets
US6878162B2 (en) 2002-08-30 2005-04-12 Edwards Lifesciences Ag Helical stent having improved flexibility and expandability
US7137184B2 (en) 2002-09-20 2006-11-21 Edwards Lifesciences Corporation Continuous heart valve support frame and method of manufacture
US7316710B1 (en) 2002-12-30 2008-01-08 Advanced Cardiovascular Systems, Inc. Flexible stent
US7571133B2 (en) 2003-03-10 2009-08-04 Chicago Mercantile Exchange, Inc. Derivatives trading methods that use a variable order price and a hedge transaction
US7399315B2 (en) 2003-03-18 2008-07-15 Edwards Lifescience Corporation Minimally-invasive heart valve with cusp positioners
US7096554B2 (en) 2003-04-04 2006-08-29 Boston Scientific Scimed, Inc. Protective loading of stents
EP1615595B1 (en) 2003-04-24 2009-10-21 Cook Incorporated Artificial valve prosthesis with improved flow dynamics
EP1635736A2 (en) 2003-06-05 2006-03-22 FlowMedica, Inc. Systems and methods for performing bi-lateral interventions or diagnosis in branched body lumens
US7959665B2 (en) 2003-07-31 2011-06-14 Abbott Cardiovascular Systems Inc. Intravascular stent with inverted end rings
US8021421B2 (en) 2003-08-22 2011-09-20 Medtronic, Inc. Prosthesis heart valve fixturing device
US20050075725A1 (en) 2003-10-02 2005-04-07 Rowe Stanton J. Implantable prosthetic valve with non-laminar flow
US9579194B2 (en) 2003-10-06 2017-02-28 Medtronic ATS Medical, Inc. Anchoring structure with concave landing zone
US20060259137A1 (en) 2003-10-06 2006-11-16 Jason Artof Minimally invasive valve replacement system
US20050075728A1 (en) 2003-10-06 2005-04-07 Nguyen Tuoc Tan Minimally invasive valve replacement system
AU2004296816A1 (en) 2003-12-04 2005-06-23 The Brigham And Women's Hospital, Inc. Aortic valve annuloplasty rings
US7261732B2 (en) * 2003-12-22 2007-08-28 Henri Justino Stent mounted valve
US8828078B2 (en) 2003-12-23 2014-09-09 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US20050137686A1 (en) 2003-12-23 2005-06-23 Sadra Medical, A Delaware Corporation Externally expandable heart valve anchor and method
US7959666B2 (en) 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
EP1718246A4 (en) 2004-02-05 2009-11-18 Childrens Medical Center TRANSCATHETER DELIVERY OF A HEARTLAPPROTHESIS
US7225518B2 (en) 2004-02-23 2007-06-05 Boston Scientific Scimed, Inc. Apparatus for crimping a stent assembly
US7207204B2 (en) 2004-02-26 2007-04-24 Boston Scientific Scimed, Inc. Crimper
US8128692B2 (en) 2004-02-27 2012-03-06 Aortx, Inc. Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same
ITTO20040135A1 (it) 2004-03-03 2004-06-03 Sorin Biomedica Cardio Spa Protesi valvolare cardiaca
EP3308744B2 (en) 2004-03-11 2023-08-02 Percutaneous Cardiovascular Solutions Pty Limited Percutaneous heart valve prosthesis
US20060004323A1 (en) 2004-04-21 2006-01-05 Exploramed Nc1, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
EP1753374A4 (en) 2004-04-23 2010-02-10 3F Therapeutics Inc IMPLANTABLE PROSTHESIS VALVE
EP1768630B1 (en) 2004-06-16 2015-01-07 Machine Solutions, Inc. Stent crimping device
US7462191B2 (en) 2004-06-30 2008-12-09 Edwards Lifesciences Pvt, Inc. Device and method for assisting in the implantation of a prosthetic valve
US7276078B2 (en) 2004-06-30 2007-10-02 Edwards Lifesciences Pvt Paravalvular leak detection, sealing, and prevention
JP2008513060A (ja) 2004-09-14 2008-05-01 エドワーズ ライフサイエンシーズ アーゲー 心臓弁逆流の処置のためのデバイスおよび方法
EP2491891A3 (en) 2004-10-02 2013-03-20 Endoheart AG Devices for embolic protection and mitral valve repair
US7316148B2 (en) 2005-02-15 2008-01-08 Boston Scientific Scimed, Inc. Protective sheet loader
US8062359B2 (en) 2005-04-06 2011-11-22 Edwards Lifesciences Corporation Highly flexible heart valve connecting band
SE531468C2 (sv) 2005-04-21 2009-04-14 Edwards Lifesciences Ag En anordning för styrning av blodflöde
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
JP4912395B2 (ja) 2005-05-24 2012-04-11 エドワーズ ライフサイエンシーズ コーポレイション 迅速配置式補綴用心臓弁
US7681430B2 (en) 2005-05-25 2010-03-23 Boston Scientific Scimed, Inc. Method and apparatus for reducing a stent
US7238200B2 (en) 2005-06-03 2007-07-03 Arbor Surgical Technologies, Inc. Apparatus and methods for making leaflets and valve prostheses including such leaflets
US20080058856A1 (en) 2005-06-28 2008-03-06 Venkatesh Ramaiah Non-occluding dilation device
US8167932B2 (en) 2005-10-18 2012-05-01 Edwards Lifesciences Corporation Heart valve delivery system with valve catheter
US8449606B2 (en) 2005-10-26 2013-05-28 Cardiosolutions, Inc. Balloon mitral spacer
US7785366B2 (en) 2005-10-26 2010-08-31 Maurer Christopher W Mitral spacer
US8778017B2 (en) 2005-10-26 2014-07-15 Cardiosolutions, Inc. Safety for mitral valve implant
US8764820B2 (en) 2005-11-16 2014-07-01 Edwards Lifesciences Corporation Transapical heart valve delivery system and method
EP1959864B1 (en) 2005-12-07 2018-03-07 Medtronic, Inc. Connection systems for two piece prosthetic heart valve assemblies
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US9078781B2 (en) 2006-01-11 2015-07-14 Medtronic, Inc. Sterile cover for compressible stents used in percutaneous device delivery systems
CN101415379B (zh) 2006-02-14 2012-06-20 萨德拉医学公司 用于输送医疗植入物的系统
US8147541B2 (en) 2006-02-27 2012-04-03 Aortx, Inc. Methods and devices for delivery of prosthetic heart valves and other prosthetics
US8219229B2 (en) 2006-03-02 2012-07-10 Edwards Lifesciences Corporation Virtual heart valve
EP2004095B1 (en) 2006-03-28 2019-06-12 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
WO2007130880A1 (en) 2006-04-29 2007-11-15 Arbor Surgical Technologies, Inc Guide shields for multiple component prosthetic heart valve assemblies and apparatus and methods for using them
US20080021546A1 (en) 2006-07-18 2008-01-24 Tim Patz System for deploying balloon-expandable heart valves
WO2008015257A2 (en) 2006-08-02 2008-02-07 Syntach Ag Luminal implant with large expansion ratio
US8052750B2 (en) 2006-09-19 2011-11-08 Medtronic Ventor Technologies Ltd Valve prosthesis fixation techniques using sandwiching
US8029556B2 (en) 2006-10-04 2011-10-04 Edwards Lifesciences Corporation Method and apparatus for reshaping a ventricle
US8052732B2 (en) 2006-11-14 2011-11-08 Medtronic Vascular, Inc. Delivery system for stent-graft with anchoring pins
US7832251B2 (en) 2006-11-15 2010-11-16 Abbott Laboratories Patterned mold for medical device
US8236045B2 (en) 2006-12-22 2012-08-07 Edwards Lifesciences Corporation Implantable prosthetic valve assembly and method of making the same
EP2111190B1 (en) 2007-01-19 2013-10-09 Medtronic, Inc. Stented heart valve devices for atrioventricular valve replacement
EP2109418A4 (en) 2007-01-26 2013-03-06 3F Therapeutics Inc METHODS AND SYSTEMS FOR REDUCING PARAVALVULAR LEAKAGE IN CARDIAC VALVES
US20080183271A1 (en) 2007-01-31 2008-07-31 Abbott Laboratories Compliant crimping sheath
US20080208327A1 (en) 2007-02-27 2008-08-28 Rowe Stanton J Method and apparatus for replacing a prosthetic valve
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8388673B2 (en) 2008-05-02 2013-03-05 Abbott Cardiovascular Systems Inc. Polymeric stent
US8002817B2 (en) 2007-05-04 2011-08-23 Abbott Cardiovascular Systems Inc. Stents with high radial strength and methods of manufacturing same
US20080294248A1 (en) 2007-05-25 2008-11-27 Medical Entrepreneurs Ii, Inc. Prosthetic Heart Valve
EP2155114B8 (en) 2007-06-04 2020-05-20 St. Jude Medical, LLC Prosthetic heart valves
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
EP2192875B1 (en) 2007-08-24 2012-05-02 St. Jude Medical, Inc. Prosthetic aortic heart valves
DE102007043830A1 (de) 2007-09-13 2009-04-02 Lozonschi, Lucian, Madison Herzklappenstent
US8425593B2 (en) 2007-09-26 2013-04-23 St. Jude Medical, Inc. Collapsible prosthetic heart valves
BRPI0819217B8 (pt) 2007-10-25 2021-06-22 Symetis Sa válvula de substituição para uso dentro de um corpo humano, sistema para substituir uma válvula dentro de um corpo humano e sistema de liberação da válvula cardíaca com stent
WO2009061389A2 (en) 2007-11-05 2009-05-14 St. Jude Medical, Inc. Collapsible/expandable prosthetic heart valves with non-expanding stent posts and retrieval features
PL2628464T5 (pl) 2007-12-14 2024-10-28 Edwards Lifesciences Corporation Zastawka protetyczna
US7972378B2 (en) 2008-01-24 2011-07-05 Medtronic, Inc. Stents for prosthetic heart valves
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
AU2009236062A1 (en) 2008-04-18 2009-10-22 Cook Medical Technologies Llc Branched vessel prosthesis
US20090276040A1 (en) 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
ATE554731T1 (de) 2008-05-16 2012-05-15 Sorin Biomedica Cardio Srl Atraumatische prothetische herzklappenprothese
US8291570B2 (en) 2008-05-30 2012-10-23 Boston Scientific Scimed, Inc. Methods for abluminally coating medical devices
US8323335B2 (en) 2008-06-20 2012-12-04 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves and methods for using
DE202009018984U1 (de) 2008-07-15 2015-01-29 St. Jude Medical, Inc. Tasche zur Verwendung in einer Herzklappenprothese
EP2334261B1 (en) 2008-07-21 2021-01-13 Jenesis Surgical, LLC Endoluminal support apparatus and method of fabricating it
AU2009295960A1 (en) 2008-09-29 2010-04-01 Cardiaq Valve Technologies, Inc. Heart valve
WO2010057262A1 (en) 2008-11-21 2010-05-27 Percutaneous Cardiovascular Solutions Pty Limited Heart valve prosthesis and method
EP4119098A1 (en) 2009-04-15 2023-01-18 Edwards Lifesciences CardiAQ LLC Vascular implant and delivery system
US8075611B2 (en) 2009-06-02 2011-12-13 Medtronic, Inc. Stented prosthetic heart valves
US8348998B2 (en) 2009-06-26 2013-01-08 Edwards Lifesciences Corporation Unitary quick connect prosthetic heart valve and deployment system and methods
US8475522B2 (en) 2009-07-14 2013-07-02 Edwards Lifesciences Corporation Transapical delivery system for heart valves
US8449599B2 (en) 2009-12-04 2013-05-28 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US8795354B2 (en) 2010-03-05 2014-08-05 Edwards Lifesciences Corporation Low-profile heart valve and delivery system
US20110224785A1 (en) * 2010-03-10 2011-09-15 Hacohen Gil Prosthetic mitral valve with tissue anchors
US8641757B2 (en) 2010-09-10 2014-02-04 Edwards Lifesciences Corporation Systems for rapidly deploying surgical heart valves
WO2012040655A2 (en) 2010-09-23 2012-03-29 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US8568475B2 (en) 2010-10-05 2013-10-29 Edwards Lifesciences Corporation Spiraled commissure attachment for prosthetic valve
US8888843B2 (en) 2011-01-28 2014-11-18 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valve regurgitation
US8945209B2 (en) 2011-05-20 2015-02-03 Edwards Lifesciences Corporation Encapsulated heart valve
US8795357B2 (en) * 2011-07-15 2014-08-05 Edwards Lifesciences Corporation Perivalvular sealing for transcatheter heart valve
US20130331929A1 (en) 2011-09-09 2013-12-12 Endoluminal Sciences Pty Ltd. Means for Controlled Sealing of Endovascular Devices
US20130190857A1 (en) 2011-09-09 2013-07-25 Endoluminal Sciences Pty Ltd. Means for controlled sealing of endovascular devices
US10016271B2 (en) * 2011-10-19 2018-07-10 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
EP4049625B1 (en) 2011-12-09 2025-01-08 Edwards Lifesciences Corporation Prosthetic heart valve having improved commissure supports
WO2013106585A1 (en) 2012-01-10 2013-07-18 White Jennifer K Articulated support structure with secondary strut features
US20130274873A1 (en) 2012-03-22 2013-10-17 Symetis Sa Transcatheter Stent-Valves and Methods, Systems and Devices for Addressing Para-Valve Leakage
US9132007B2 (en) 2013-01-10 2015-09-15 Medtronic CV Luxembourg S.a.r.l. Anti-paravalvular leakage components for a transcatheter valve prosthesis
US9439763B2 (en) 2013-02-04 2016-09-13 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US9168129B2 (en) * 2013-02-12 2015-10-27 Edwards Lifesciences Corporation Artificial heart valve with scalloped frame design
US9636222B2 (en) 2013-03-12 2017-05-02 St. Jude Medical, Cardiology Division, Inc. Paravalvular leak protection
US8986375B2 (en) 2013-03-12 2015-03-24 Medtronic, Inc. Anti-paravalvular leakage component for a transcatheter valve prosthesis
PT2967834T (pt) * 2013-03-13 2021-03-29 Jenesis Surgical Llc Stents de válvula de comissura articulada
US9326856B2 (en) 2013-03-14 2016-05-03 St. Jude Medical, Cardiology Division, Inc. Cuff configurations for prosthetic heart valve
EP2991585B1 (en) 2013-05-03 2023-08-16 Medtronic Inc. Medical devices for implanting in a valve
ES2908132T3 (es) 2013-05-20 2022-04-27 Edwards Lifesciences Corp Aparato de suministro de válvula cardiaca protésica
EP3043745B2 (en) 2013-09-12 2026-01-28 St. Jude Medical, Cardiology Division, Inc. Stent designs for prosthetic heart valves
US10098734B2 (en) 2013-12-05 2018-10-16 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
WO2015152980A1 (en) * 2014-03-31 2015-10-08 St. Jude Medical, Cardiology Division, Inc. Paravalvular sealing via extended cuff mechanisms
US10195025B2 (en) * 2014-05-12 2019-02-05 Edwards Lifesciences Corporation Prosthetic heart valve
US9974650B2 (en) * 2015-07-14 2018-05-22 Edwards Lifesciences Corporation Prosthetic heart valve
US9895222B2 (en) * 2015-08-17 2018-02-20 Venus Medtech (Hangzhou) Inc. Aortic replacement valve
US11096781B2 (en) 2016-08-01 2021-08-24 Edwards Lifesciences Corporation Prosthetic heart valve
US10575944B2 (en) * 2016-09-22 2020-03-03 Edwards Lifesciences Corporation Prosthetic heart valve with reduced stitching
US11185406B2 (en) * 2017-01-23 2021-11-30 Edwards Lifesciences Corporation Covered prosthetic heart valve
US11135056B2 (en) 2017-05-15 2021-10-05 Edwards Lifesciences Corporation Devices and methods of commissure formation for prosthetic heart valve
IL309520B2 (en) * 2017-05-31 2026-02-01 Edwards Lifesciences Corp Sealing component for heart valve bushing
US10869759B2 (en) 2017-06-05 2020-12-22 Edwards Lifesciences Corporation Mechanically expandable heart valve

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393360B2 (en) 2001-10-11 2008-07-01 Edwards Lifesciences Pvt, Inc. Implantable prosthetic valve
US7510575B2 (en) 2001-10-11 2009-03-31 Edwards Lifesciences Corporation Implantable prosthetic valve
US6730118B2 (en) 2001-10-11 2004-05-04 Percutaneous Valve Technologies, Inc. Implantable prosthetic valve
US20070005131A1 (en) 2005-06-13 2007-01-04 Taylor David M Heart valve delivery system
US20080065011A1 (en) 2006-09-08 2008-03-13 Philippe Marchand Integrated heart valve delivery system
US20090281619A1 (en) 2008-05-09 2009-11-12 Edwards Lifesciences Corporation Low Profile Delivery System for Transcatheter Heart Valve
US7993394B2 (en) 2008-06-06 2011-08-09 Ilia Hariton Low profile transcatheter heart valve
US8652202B2 (en) 2008-08-22 2014-02-18 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
US20100049313A1 (en) 2008-08-22 2010-02-25 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
WO2012048035A2 (en) * 2010-10-05 2012-04-12 Edwards Lifesciences Corporation Prosthetic heart valve
US20130030519A1 (en) 2011-07-27 2013-01-31 Edwards Lifesciences Corporation Delivery systems for prosthetic heart valve
US20140296962A1 (en) 2011-10-21 2014-10-02 Syntheon Cardiology, Llc Actively Controllable Stent, Stent Graft, Heart Valve and Method of Controlling Same
US20150135506A1 (en) 2013-11-11 2015-05-21 Jenesis Surgical, Llc Systems and methods for manufacturing a stent frame
US20170065408A1 (en) * 2014-05-06 2017-03-09 Dsm Ip Assets B.V. Method of making a prosthetic valve and valve obtained therewith
US20160317305A1 (en) * 2015-04-29 2016-11-03 Edwards Lifesciences Corporation Laminated sealing member for prosthetic heart valve
US20180133003A1 (en) * 2016-11-17 2018-05-17 Edwards Lifesciences Corporation Prosthetic heart valve having leaflet inflow below frame
US20180153689A1 (en) 2016-12-06 2018-06-07 Edwards Lifesciences Corporation Mechanically expanding heart valve and delivery apparatus therefor

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021141878A1 (en) 2020-01-10 2021-07-15 Edwards Lifesciences Corporation Assembly methods for a prosthetic heart valve leaflet
WO2021188609A2 (en) 2020-03-17 2021-09-23 Edwards Lifesciences Corporation Modification of existing valvular structures for prosthetic heart valve implantation
WO2021242952A1 (en) 2020-05-28 2021-12-02 Edwards Lifesciences Corporation Methods and devices for leaflet folding or capture
WO2022076508A1 (en) * 2020-10-06 2022-04-14 Edwards Lifesciences Corporation Protective covers for prosthetic valves
WO2022103747A1 (en) 2020-11-10 2022-05-19 Edwards Lifesciences Corporation Prosthetic heart valves with hermetic layers or valvular structures to reduce thrombosis risk
WO2022103845A1 (en) 2020-11-11 2022-05-19 Edwards Lifesciences Corporation Prosthetic heart valves with sealing frames to reduce paravalvular leakage
WO2022226150A1 (en) 2021-04-22 2022-10-27 Edwards Lifesciences Corporation Prosthetic heart valves with ratcheting lock mechanisms, and methods for fabrication and use
WO2025101895A1 (en) 2023-11-09 2025-05-15 Edwards Lifesciences Corporation Percutaneous valve leaflet modification

Also Published As

Publication number Publication date
US20250090318A1 (en) 2025-03-20
JP7662526B2 (ja) 2025-04-15
JP2025096362A (ja) 2025-06-26
EP4541318A2 (en) 2025-04-23
US20250169947A1 (en) 2025-05-29
CN113613594A (zh) 2021-11-05
EP3917453A1 (en) 2021-12-08
EP3917453B1 (en) 2026-04-22
CN119857008A (zh) 2025-04-22
CN113613594B (zh) 2024-11-26
US12201519B2 (en) 2025-01-21
JP2022518919A (ja) 2022-03-17
US20210322162A1 (en) 2021-10-21
EP4541318A3 (en) 2025-07-16

Similar Documents

Publication Publication Date Title
US12201519B2 (en) Prosthetic valve
US12186185B2 (en) Prosthetic heart valve
US20240382306A1 (en) Prosthetic heart valve
US12232956B2 (en) Prosthetic heart valve leaflet assemblies and methods
US20220387175A1 (en) Prosthetic heart valve
US20220409368A1 (en) Prosthetic heart valve leaflet assemblies and methods
US12594159B2 (en) Sealing member for prosthetic heart valve
EP4013352A1 (en) Prosthetic heart valve having at least two types of struts
EP3975934B1 (en) Prosthetic heart valve
US20230190459A1 (en) Prosthetic heart valve and methods for assembly
US20230051890A1 (en) Leaflet attachment in prosthetic heart valves using buckle commissure clamps
HK40078969A (en) Prosthetic heart valve

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20706922

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021543425

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2020706922

Country of ref document: EP

Effective date: 20210830

WWG Wipo information: grant in national office

Ref document number: 2020706922

Country of ref document: EP